日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Repair of damaged lysosomes by TECPR1-mediated membrane tubulation during energy crisis.

能量危机期间,TECPR1介导的膜管化修复受损溶酶体。

Chen Hanmo, Zhang Chaojun, Fu Yuhui, Li Linsen, Qiao Xiaoyu, Zhang Shen, Luo Hanyan, Chen She, Liu Xiaoxia, Zhong Qing

Targeting BCMA in Plasmablastic Lymphoma With Teclistamab: A Case Study of Three Patients.

使用Teclistamab靶向BCMA治疗浆母细胞淋巴瘤:三例患者的病例研究。

Cannova Joseph M, DuVall Adam S, Kline Justin, Feinberg Nicholas, Wool Geoffrey D, Riedell Peter A

Attenuating ETEC virulence using a heat-labile enterotoxin-blocking binding protein

利用热不稳定肠毒素阻断结合蛋白减弱ETEC毒力

Petersson, Marcus; Pettersen, Jens Sivkær; Henriksen, Helena Bay; Duzs, Ágnes; Fernández-Quintero, Monica L; Burlet, Nick Jean; Mojica, Natalia; Krengel, Ute; Jenkins, Timothy P; Ward, Andrew B; Andersen, Thomas Emil; Møller-Jensen, Jakob; Gram, Lone; Laustsen, Andreas Hougaard; Thrane, Sandra Wingaard

Claudin 1-mediated positioning of DC1 to mTECs is essential for maintenance of central tolerance

Claudin 1介导的DC1向mTEC的定位对于维持中枢耐受性至关重要。

Březina, Jiří; Brabec, Tomáš; Machač, David; Vobořil, Matouš; Ballek, Ondřej; Pačes, Jan; Sýkora, Vojtěch; Jančovičová, Kristína; Valter, Evgeny; Kováčová, Katarína; Manning, Jasper; Tahtahová, Valerie; Čepková, Adéla; Dobešová, Martina; Dobeš, Jan; Kubovčiak, Jan; Kolář, Michal; Kašpárek, Petr; Sedlacek, Radislav; Štepánek, Ondřej; Černý, Jan; Tsukita, Sachiko; Malissen, Bernard; Anderson, Graham; Filipp, Dominik

Quantitative HER2 tissue and plasma profiling predicts the activity of trastuzumab deruxtecan for breast cancer.

定量 HER2 组织和血浆分析可预测曲妥珠单抗 deruxtecan 对乳腺癌的活性。

Tarantino Paolo, Kim Se-Eun, Hughes Melissa E, Kusmick Ross J, Smith Kalie, Brasó-Maristany Fara, Nyein Chan Nay Nwe, Paré Brunet Laia, Alder Laura, Garcia-Cortes Diana, Gomez Tejeda Zanudo Jorge, Pereslete Alyssa M, Noteware Laura, Moore Heather, Van Swearingen Amanda E D, Li Tianyu, Gupta Hersh, D'Amico Olivia, Martini Alba, Morganti Stefania, Spindel Jennifer, Cook Charmaine, McLaughlin Christine, Dvir Kathrin, Garrido-Castro Ana C, Sammons Sarah, Files Janet, Sendrick Kerry, Buck Simone, Dillon Deborah, Jeselsohn Rinath, Li Yvonne Y, Cherniack Andrew D, LoRusso Patricia, Lustberg Maryam, Vega-León Rosario, Pardo Francisco, Davis Justin, Mueller Claudius, Corgiat Brian, Curigliano Giuseppe, Anders Carey K, Petricoin Emanuel F, Rimm David L, Prat Aleix, Tayob Nabihah, Lin Nancy U, Tolaney Sara M

The protective role of a moderate protein diet in ETEC-infected piglets: Optimization of growth, immunity, and microbial balance

适量蛋白质饮食对感染肠毒素大肠杆菌(ETEC)仔猪的保护作用:优化生长、免疫和微生物平衡

Li, Minmin; Wang, Mingyu; Chen, Yuhan; Chen, Daiwen; Yu, Bing; He, Jun; Yu, Jie; Mao, Xiangbing; Huang, Zhiqing; Luo, Yuheng; Luo, Junqiu; Yan, Hui; Zheng, Ping

Association between Complete Proteinuria Remission and Kidney Function in the Phase 3 PROTECT Trial of Sparsentan in IgA Nephropathy

在 Sparsentan 治疗 IgA 肾病的 3 期 PROTECT 试验中,完全蛋白尿缓解与肾功能之间的关联

Heerspink, Hiddo J L; Rovin, Brad H; Komers, Radko; Hendry, Bruce; Mercer, Alex; Preciado, Priscila; Murphy, Edward; Tesar, Vladimir

High-dose chemotherapy in male germ cell cancer patients-a study by the SWENOTECA group

男性生殖细胞癌患者的高剂量化疗——SWENOTECA 研究组的研究

Jansson, Anna K; Cohn-Cedermark, Gabriella; Negaard, Helene F S; Tandstad, Torgrim; Ståhl, Olof; Hedlund, Annika; Karlsdottir, Åsa; Hellström, Martin; Langberg, Carl W; Sköld, Camilla; Haugnes, Hege S; Glimelius, Ingrid

Molecular determinants of STEC-HUS: from complement activation to microvascular thrombosis

STEC-HUS的分子决定因素:从补体激活到微血管血栓形成

Santarsiero, Donata; Galbusera, Miriam; Gastoldi, Sara; Bresin, Elena; Piras, Rossella; Alberti, Marta; Vivarelli, Marina; Prandini, Silvia; Conti, Sara; Zotta, Federica; Schubart, Anna; Benigni, Ariela; Remuzzi, Giuseppe; Noris, Marina; Aiello, Sistiana

The role of JAK3 and TEC family kinases in vitiligo pathogenesis

JAK3和TEC家族激酶在白癜风发病机制中的作用

Passeron, Thierry; Seneschal, Julien; Picardo, Mauro; Xiang, Leihong; Tanemura, Atsushi; Winkler, Aaron; Telliez, Jean-Baptiste; Adiri, Roni